Mitomycin
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) (NCT05316181) | National Cancer Center, Korea | 2022-04-07 |
Track Mitomycin automatically
Every clearance here is in the API, with alerts when new ones post.